Indeed, a review study in which PD-L1 tumor expression was assessed in NSCLC patients revealed high discrepancies from association of PD-L1 expression with better prognosis, worse prognosis, or no prognosis at all [21]. Here, CD274 is linked to non-small cell lung carcinoma.